These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36963882)

  • 41. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative chest computerized tomography and FEV
    Sanders DB; Li Z; Parker-McGill K; Farrell P; Brody AS
    Pediatr Pulmonol; 2018 Oct; 53(10):1369-1377. PubMed ID: 30160050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
    Lands LC; Stanojevic S
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D deficiency is associated with pulmonary dysfunction in cystic fibrosis.
    Sexauer WP; Hadeh A; Ohman-Strickland PA; Zanni RL; Varlotta L; Holsclaw D; Fiel S; Graff GR; Atlas A; Bisberg D; Hadjiliadis D; Michel SH; Mintz D; Chakraborty R; Marra B; Lomas P; Ward T; Sassman M; Imbesi GC; Kitch DM; Mallowe AM
    J Cyst Fibros; 2015 Jul; 14(4):497-506. PubMed ID: 25577127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis.
    Abu-Fraiha Y; Elyashar-Earon H; Shoseyov D; Cohen-Cymberknoh M; Armoni S; Kerem E; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):110-115. PubMed ID: 30095576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of national antenatal vitamin D supplementation programme puts dark skinned infants at highest risk: A newborn bloodspot screening study.
    Uday S; Naseem S; Large J; Denmeade R; Goddard P; Preece MA; Dunn R; Fraser W; Tang JCY; Högler W
    Clin Nutr; 2021 May; 40(5):3542-3551. PubMed ID: 33358424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D Supplementation for Childhood Asthma: A Systematic Review and Meta-Analysis.
    Riverin BD; Maguire JL; Li P
    PLoS One; 2015; 10(8):e0136841. PubMed ID: 26322509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
    Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
    J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhaled corticosteroids for cystic fibrosis.
    Balfour-Lynn IM; Welch K; Smith S
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001915. PubMed ID: 31271656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009422. PubMed ID: 25489958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007298. PubMed ID: 22513949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
    Konstan MW; Wagener JS; Pasta DJ; Millar SJ; Jacobs JR; Yegin A; Morgan WJ;
    Pediatr Pulmonol; 2011 Jun; 46(6):545-53. PubMed ID: 21438174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007298. PubMed ID: 19821402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.